Kenneth Krogulski, Director at CUMBERLAND PHARMACEUTICALS INC (CPIX), bought 1,956 shares at $4.36 ($9K) on 2021-12-13, disclosed to the SEC on 2022-01-07.
Scheduled purchase ($9k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $4.14 | 75 | $311 | 3.5% |
| 2 | $3.84 | 75 | $288 | 3.3% |
| 3 | $4.47 | 75 | $335 | 3.8% |
| 4 | $4.46 | 75 | $335 | 3.8% |
| 5 | $5.61 | 75 | $421 | 4.8% |
| 6 | $6.15 | 75 |
| $461 |
| 5.2% |
| 7 | $5.81 | 75 | $436 | 4.9% |
| 8 | $4.82 | 75 | $362 | 4.1% |
| 9 | $4.36 | 200 | $872 | 9.9% |
| 10 | $4.28 | 200 | $856 | 9.7% |
| 11 | $4.29 | 200 | $858 | 9.7% |
| 12 | $4.53 | 240 | $1K | 12.3% |
| 13 | $4.17 | 240 | $1K | 11.4% |
| 14 | $4.33 | 276 | $1K | 13.6% |
| Total | $4.51 avg | 1,956 | $9K | 100% |
| Filing → |
| CPIX | BUY | 2025-07-11 | $5K | — | Filing → |
| CPIX | BUY | 2025-06-06 | $5K | — | Filing → |
| CPIX | BUY | 2025-05-09 | $5K | — | Filing → |